Αρχική World News Sleep Issue Called Hypersomnolence Can Increase The Risk Of Diabetes And Cancer...

Sleep Issue Called Hypersomnolence Can Increase The Risk Of Diabetes And Cancer In Elderly People

Excessive drowsiness during the day could be an indication that something more sinister is happening in the body.It’s a condition called hypersomnolence. It can affect a person’s daily life to the point of being debilitating, as they may fall asleep at work, during an event or meal, or while having a conversation with other people.A red flag for the condition is being excessively tired and needing to nap repeatedly during the day even after seven or more hours of sleep at night. Other key signs and symptoms of hypersomnolence include: frequent naps within the same day, not feeling rested or refreshed after a full night’s sleep, problems fully waking up from a long stretch of sleep, and feeling confused or disoriented for minutes or hours after waking. These symptoms need to occur at least three times a week for three months in order to be considered as hypersomnolence.Previous research has seen a link between excessive drowsiness during the day and mental decline, memory issues, and even Alzheimer’s.Photo: Adobe Stock/Seventyfour
If an individual experiences hypersomnolence and they’re over the age of 65, they may be at risk of developing other medical conditions such as cancer, high blood pressure, and diabetes, the study found.The results were published in the American Academy of Neurology.Researchers spoke with 10,930 people over the phone on two separate occasions, three years apart, and asked them a series of questions about their sleep habits and health. Roughly a third of the participants (34%) were at least 65 years old at the time of the first phone interview.Photo: Adobe Stock/Mladen
In the first round of phone calls, 23% of participants over 65 (840 people) were deemed to have hypersomnolence.Of those 840 people, 52 of them (6.2%) developed diabetes three years later. Of the seniors who reported they were never sleepy during the day at the first interview, only 74 people (2.9%) developed diabetes.Those who reported hypersomnolence at the first interview also had a higher incidence of cancer, with 20 of them (2.4%) developing cancer, compared to only 21 people (0.8%) in the non-drowsy group. Seniors with hypersomnolence also had a 2.3 times greater risk of developing high blood pressure compared to the other group.Photo Credit: Adobe Stock/Monkey Business
In the second interview, around a quarter (24%) of seniors over 65 reported excessive sleepiness. Of that quarter, 41% said the sleepiness was a chronic problem.The seniors who reported hypersomnolence only in the second interview were 50% more likely to have diseases like arthritis, tendinitis, and lupus (diseases of the musculoskeletal system and connective tissue) compared to those who did not have daytime sleepiness.Participants who reported hypersomnolence during both interviews had a 2.5 times greater risk of developing heart disease compared to those who did not.Photo: Adobe Stock/doupix
Dr. Maurice M. Ohayon, M.D., Ph.D., DSc, of Stanford University in California, is one of the study’s authors and a member of the American Academy of Neurology.“Paying attention to sleepiness in older adults could help doctors predict and prevent future medical conditions,” Ohayon said. “Older adults and their family members may want to take a closer look at sleeping habits to understand the potential risk for developing a more serious medical condition.”Researchers adjusted for other factors that could affect sleepiness, such as sleep apnea, to get these results. One limitation of the study, however, is that the data was pulled from the participants’ memories rather than sleep studies in a sleep clinic or something similar.Source

NEWSLETTER

Συμπληρώστε το email σας για να λαμβάνετε τις σημαντικότερες ειδήσεις από το ogkologos.com

Βρείτε μας

2,449ΥποστηρικτέςΚάντε Like
57ΑκόλουθοιΑκολουθήστε

Διαβαστε Επίσης

ΕΞΕΛΙΞΕΙΣ ΣΤΗ ΘΕΡΑΠΕΙΑ ΤΟΥ ΜΗ-ΜΙΚΡΟΚΥΤΤΑΡΙΚΟΥ ΚΑΡΚΙΝΟΥ ΤΟΥ ΠΝΕΥΜΟΝΑ (ΜΜΚΠ)

ΕΞΕΛΙΞΕΙΣ ΣΤΗ ΘΕΡΑΠΕΙΑ ΤΟΥ ΜΗ-ΜΙΚΡΟΚΥΤΤΑΡΙΚΟΥ ΚΑΡΚΙΝΟΥ ΤΟΥ ΠΝΕΥΜΟΝΑ (ΜΜΚΠ) Γράφει ο Δρ Παπαδούρης Σάββας, Παθόλογος-Ογκολόγος   Ο ΜΜΚΠ βρίσκεται αναλογικά στο 80% και πλέον του συνολικού...

Διατρέχουν όντως οι καρκινοπαθείς μεγαλύτερο κίνδυνο λόγω κοροναϊού;

Σε πρακτικό επίπεδο, τα δεδομένα των σχετικών μελετών υποδηλώνουν ότι η χημειοθεραπεία ή οι άλλες αντι-νεοπλασματικές θεραπείες δεν αυξάνουν σημαντικά τον κίνδυνο θνησιμότητας από...

FDA: Η ακτινοβολία των smartphones δεν προκαλεί καρκίνο

Σε μια νέα έκθεσή της, η Υπηρεσία Τροφίμων και Φαρμάκων (FDA) των ΗΠΑ αναφέρει ότι επανεξέτασε τις σχετικές επιστημονικές έρευνες που δημοσιεύθηκαν τα τελευταία...

Νέα ανακάλυψη, νέα ελπίδα για τον καρκίνο

Ένα νεοανακαλυφθέν τμήμα του ανοσοποιητικού μας συστήματος θα μπορούσε να αξιοποιηθεί για την αντιμετώπιση όλων των ειδών καρκίνου, σύμφωνα με επιστήμονες του πανεπιστημίου Cardiff...

Καρκίνος: Ευεργετική για τους καρκινοπαθείς η άσκηση

Σημαντικά ωφέλη προσφέρει η άσκηση, ακόμη και σε ασθενείς με καρκίνο. Οι περισσότεροι ασθενείς αγνοούν τα οφέλη που μπορεί να έχει γι’ αυτούς η συχνή...

Prostate Cancer

The article is provided by Scientific Communications Officer of NIPD Genetics, Ms Marina Charitou (MSc) Prostate Cancer Awareness Prostate cancer is the second most common cancer...
- Advertisment -

Ροή Ειδήσεων

ESMO 2020: New Treatments for Advanced Kidney Cancer, Prostate Cancer, and Bladder Cancer

The 2020 European Society for Medical Oncology (ESMO) Virtual Congress was held online from September 19 to September 21. In this podcast, Neeraj Agarwal,...

The UK Government’s spending review: Time to invest in the future of cancer care

This autumn, the chancellor Rishi Sunak will go to Parliament and set out the UK Government’s spending priorities in the Comprehensive Spending Review...

FDA Extends Approval of Pembrolizumab for Classical Hodgkin Lymphoma

On 14 October 2020, the US Food and Drug Administration (FDA) extended the approval of pembrolizumab (KEYTRUDA®, Merck Sharp & Dohme Corp.) for the...

31-Year-Old Mother Dies of Cancer After Her Chemotherapy Was Paused During the Pandemic

The COVID-19 pandemic has been a scary and difficult thing for most of the world, and it’s important to keep safety protocols in place...

For Esophageal Cancer, Immunotherapy Likely to Play Larger Role

October 19, 2020, by NCI Staff An esophagram using barium contrast shows the esophagus. Credit: iStock Immunotherapy may become part of early treatment for some people with...

Targeted Therapy Based on Molecular Profiling of Malignant Mesothelioma Tumours Is Feasible

Targeted therapy recommendations can be made based on the molecular profiles of tumour samples from patients with metastatic malignant mesothelioma (MM) according to findings...